The Potential Protective Role of Naringenin against Dasatinib-Induced Hepatotoxicity

Dasatinib (DASA) is a novel tyrosine kinase inhibitor, approved for leukemia treatment. However, the long-term use of DASA induces several complications, especially liver damage. On the other hand, Naringenin (NGN) is a potent antioxidant and anti-inflammatory agent which is known to exert protectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanazi, Ahmed Z., Alhazzani, Khalid, Alrewily, Salah Q., Aljerian, Khaldoon, Algahtani, Mohammad M., Alqahtani, Qamraa H., Haspula, Dhanush, Alhamed, Abdullah S., Alqinyah, Mohammed, Raish, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383559/
https://www.ncbi.nlm.nih.gov/pubmed/37513833
http://dx.doi.org/10.3390/ph16070921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383559/
https://www.ncbi.nlm.nih.gov/pubmed/37513833
http://dx.doi.org/10.3390/ph16070921

Ejemplares similares